- Home
- NUWE vs ATNF Comparison
NUWE vs ATNF Comparison
Compare NUWE & ATNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUWE
- ATNF
- Stock Information
- Founded
- NUWE 1999
- ATNF 2016
- Country
- NUWE United States
- ATNF United States
- Employees
- NUWE N/A
- ATNF N/A
- Industry
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ATNF Biotechnology: Pharmaceutical Preparations
- Sector
- NUWE Health Care
- ATNF Health Care
- Exchange
- NUWE Nasdaq
- ATNF Nasdaq
- Market Cap
- NUWE 5.2M
- ATNF 4.6M
- IPO Year
- NUWE N/A
- ATNF N/A
- Fundamental
- Price
- NUWE $1.27
- ATNF $1.40
- Analyst Decision
- NUWE Strong Buy
- ATNF
- Analyst Count
- NUWE 1
- ATNF 0
- Target Price
- NUWE $17.00
- ATNF N/A
- AVG Volume (30 Days)
- NUWE 1.1M
- ATNF 214.4K
- Earning Date
- NUWE 03-04-2025
- ATNF 02-13-2025
- Dividend Yield
- NUWE N/A
- ATNF N/A
- EPS Growth
- NUWE N/A
- ATNF N/A
- EPS
- NUWE N/A
- ATNF N/A
- Revenue
- NUWE $8,969,000.00
- ATNF N/A
- Revenue This Year
- NUWE $2.18
- ATNF N/A
- Revenue Next Year
- NUWE $25.75
- ATNF $54.15
- P/E Ratio
- NUWE N/A
- ATNF N/A
- Revenue Growth
- NUWE 3.66
- ATNF N/A
- 52 Week Low
- NUWE $0.92
- ATNF $1.16
- 52 Week High
- NUWE $27.65
- ATNF $17.75
- Technical
- Relative Strength Index (RSI)
- NUWE 55.34
- ATNF 39.49
- Support Level
- NUWE $1.15
- ATNF $1.31
- Resistance Level
- NUWE $1.67
- ATNF $1.51
- Average True Range (ATR)
- NUWE 0.15
- ATNF 0.11
- MACD
- NUWE 0.01
- ATNF 0.01
- Stochastic Oscillator
- NUWE 36.51
- ATNF 24.35
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical device company. Its solutions includes Aquadex Smartflow System and RenalSense Clarity RMS. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Clarity RMS is a kidney monitoring system that continuously measures urine output and flows, automatically displaying real-time data to the medical staff.
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.